Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-03
1999-06-29
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514562, 514629, A61K 31335, A61K 31195, A61K 3116
Patent
active
059169133
ABSTRACT:
The present invention uses Paclitaxel and/or Colchicine in an appropriate carrier to inhibit wound contraction. Paclitaxel is an antimicrotubule agent that is currently used as a cancer chemotherapeutic drug. Colchicine inhibits microtubule dependent processes such as cell contraction and motility. It has been given orally for decades to treat gout. Previous studies using Colchicine to control wound contraction have been unsuccessful because of both local and systemic toxicity. Studies using the present invention demonstrate that Paclitaxel and Colchicine, when applied to wounds locally (either topically or by injection) in concentrations which are much lower than those previously studied, inhibit wound contraction, collagen deposition and granulation tissue growth. When combined with D-penicillamine, a drug that inhibits collagen cross-linking, the combination inhibits wound contraction, granulation tissue growth (nascent tissue that forms in the wound immediately post-injury), and intramuscular collagen deposition; epithelialization (sealing of the wound) is promoted.
REFERENCES:
patent: 4485088 (1984-11-01), Chvapil
Damji, et al., Pharmacologic Modulation of Human Subconjunctival Fibroblast Behavior in Vitro, Ophthalmic. Surg., vol. 21, No. 1, pp. 31-43, 1990.
Ehrilich, et al., Evidence for the Involvment of Microtubules in Wound Contraction, Am. J. Surg., vol. 133, pp. 706-709, 1977.
Joseph et al., Inhibition of Wound Contraction with Colchicine and D-Penicillamine, Journal of Surgical Research, vol. 61, No. 1, pp. 197-200, 1996.
Rennard, et al., Colchicine Suppress the Release of Fibroblast Growth Factors from Alveolar Macrophages in Vitro, Am. Rev. Respir. Dis., vol. 137, pp. 181-185, 1988.
Rennekampff, et al., Reduction of Capsular Formation Around Silicon Breast Implants by D-D-Pencillamine in Rats, Scand. J. Plast. Reconstr. Surg. Hand. Sur., vol. 26, No. 3, pp. 253-255, 1992.
McGrath, et al, The Spatial and Temporal Quantification of Myofibroblasts, Plastic and Reconstructive Surgery, pp. 975-981, Jun. (1982).
Joseph et al. J. Surg. Res., 61 (1), 197-200 (Abstract), 1996.
LandOfFree
Inhibition of wound contraction with paclitaxel, colchicine and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of wound contraction with paclitaxel, colchicine and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of wound contraction with paclitaxel, colchicine and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1375679